Medicine is our platform. Accessibility is our cure.
Structure Therapeutics is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop oral small molecule therapeutics for chronic diseases including obesity. The company's platform applies proprietary GPCR structural knowledge and computational chemistry to build a broad pipeline of non-peptide medicines that are more scalable and accessible than biologics or injectable peptide therapies.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2026
Oct 2021
Create a free account to see which investors have funded this company.
Create Free Account
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
Research-based development stage biopharmaceutical company that discovers and develops innovative...
Clinical-stage biopharmaceutical company developing T cell receptor-based adoptive cell therapies...
